- Home
- THRD vs LX Comparison
THRD vs LX Comparison
Compare THRD & LX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- LX
- Stock Information
- Founded
- THRD 2019
- LX 2013
- Country
- THRD United States
- LX China
- Employees
- THRD N/A
- LX N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- LX Finance: Consumer Services
- Sector
- THRD Health Care
- LX Finance
- Exchange
- THRD Nasdaq
- LX Nasdaq
- Market Cap
- THRD 512.9M
- LX 526.1M
- IPO Year
- THRD 2022
- LX 2017
- Fundamental
- Price
- THRD $13.93
- LX $3.88
- Analyst Decision
- THRD Strong Buy
- LX Hold
- Analyst Count
- THRD 3
- LX 1
- Target Price
- THRD $20.33
- LX $2.12
- AVG Volume (30 Days)
- THRD 184.1K
- LX 4.0M
- Earning Date
- THRD 11-07-2024
- LX 11-20-2024
- Dividend Yield
- THRD N/A
- LX 3.53%
- EPS Growth
- THRD N/A
- LX N/A
- EPS
- THRD N/A
- LX 0.68
- Revenue
- THRD N/A
- LX $1,912,918,711.00
- Revenue This Year
- THRD N/A
- LX $7.47
- Revenue Next Year
- THRD N/A
- LX $3.86
- P/E Ratio
- THRD N/A
- LX $5.30
- Revenue Growth
- THRD N/A
- LX 18.01
- 52 Week Low
- THRD $5.82
- LX $1.56
- 52 Week High
- THRD $16.94
- LX $4.70
- Technical
- Relative Strength Index (RSI)
- THRD 54.76
- LX 65.74
- Support Level
- THRD $11.69
- LX $3.33
- Resistance Level
- THRD $14.64
- LX $3.84
- Average True Range (ATR)
- THRD 0.99
- LX 0.27
- MACD
- THRD -0.04
- LX 0.01
- Stochastic Oscillator
- THRD 67.67
- LX 81.07
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.